Carregant...
Everolimus in the Treatment of Metastatic Breast Cancer
The discovery of the mammalian target of rapamycin (mTOR) molecular pathway has brought insight into its vital role in breast cancer pathogenesis. Several clinical trials have shown that the mTOR inhibitor everolimus could improve patient outcomes in several subtypes of breast cancer, including horm...
Guardat en:
| Publicat a: | Breast Cancer (Auckl) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Libertas Academica
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571987/ https://ncbi.nlm.nih.gov/pubmed/26417203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S29268 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|